Adrenal medulla and paraganglia

Endocrine Pathology: Differential Diagnosis and Molecular Advances

Volumn , Issue , 2010, Pages 281-295

  McNicol, Anne Marie ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Paraganglioma; Parasympathetic; Pheochromocytoma; Sympathetic

Indexed keywords

EID: 81755179349     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-1069-1_12     Document Type: Chapter

References (183)

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) Tumours of Endocrine Organs. In: Kleihues P, Sobin LH (eds)) World Health Organization classifcation of tumours. IARC Press, Lyon
2. Kohn A (1903) Die Paraganglien. Arch Mikr Anat 52:262-365
3. Stilling H (1898) Die chromophilen Zellen und Korperchen des Sympathicus. Eine Berichtigung. Anat Anz 15:229-233
4. Watzka M (1934) Vom paraganglion caroticum. Anat Anz 78:108-120
5. Addison T (1937) On the constitutional and local effects of disease of the suprarenal capsules. 1855. In a collection of the published writings of the late Thomas Addison MD, physician to Guy's Hospital, London. New Sydenham Society, London, 1868. Med Classics 2:244-293
6. Oliver G, Schafer EA (1894) On the physiological action of extract of the suprarenal capsules. J Physiol 16:i-iv
7. Abel JJ, Crawford AC (1897) On the blood-pressure-raising constituent of the suprarenal capsule. Johns Hopkins Hosp Bull 8:151-157
8. Takamine J (1901/1902) The isolation of the active principle of the suprarenal gland. J Physiol London 27:xxix-xxx
9. von Euler US, Hamberg U (1949) 1-Noradrenaline in the suprarenal medulla. Nature 163:642-643
10. Hillarp NA, Lagerstedt S, Nilson B (1953) The isolation of granular fraction from the supra renal medulla containing the sympath-omimetic amines. Acta Physiol Scand 29:251-263
11. Blaschko H, Welch AD (1953) Localization of adrenaline in cyto-plasmic particles of the bovine adrenal medulla. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 219:17-22
12. Lack E (1994) Major problems in pathology. In: LiVolsi VA (ed)) Pathology of adrenal and extra-adrenal paraganglia. W.B. Saunders, Philadelphia, PA
13. Coupland RE (1954) Postnatal fate of the abdominal paraaortic bodies in man. J Anat 88:464
14. Hervonen A, Vaalasti A, Partanen M, Kanerva L, Vaalasti T (1976) The paraganglia, a persisting endocrine system in man. Am J Anat 146:207-210
15. Jacobowitz D (1967) Histochemical studies of the relationship of chromaffn cells and adrenergic nerve fbers to the cardiac ganglia of several species. J Pharmacol Exp Ther 158:227-240
16. Grillo MA, Jacobs L, Comroe JH (1974) A combined fuorescence histochemical and electron microscopic method for studying special monoamine containing cells (SIF cells). J Comp Neurol 153:1-14
17. Kuo T, Anderson CB, Rosai J (1974) Normal paraganglia in the human gallbladder. Arch Pathol 97:46-47
18. Kawabata K (1999) Paraganglia of the gallbladder: a report of two cases with an immunohistochemical study. Pathol Res Pract 195:781-786
19. Wong DL (2006) Epinephrine biosynthesis: hormonal and neural control during stress. Cell Mol Neurobiol 26:891-900
20. Park JJ, Koshimizu H, Loh YP (2008) Biogenesis and transport of secretory granules to release site in neuroendocrine cells. J Mol Neurosci 37(2):151-159
21. Montero-Hadjadje M, Vaingankar S, Elias S et al (2008) Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf) 192:309-324
22. Feldman SA, Eiden LE (2003) The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroen-docrine neoplasia. Endocr Pathol 14:3-23
23. Spinazzi R, Andreis PG, Nussdorfer GG (2005) Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions. Int J Mol Med 15:3-13
24. Tortorella C, Neri G, Nussdorfer GG (2007) Galanin in the regulation of the hypothalamic-pituitary-adrenal axis (Review). Int J Mol Med 19:639-647
25. Kapas S, Hinson JP (2002) Adrenomedullin in the adrenal. Microsc Res Tech 57:91-97
26. Mazzocchi G, Malendowicz LK, Rebuffat P, Gottardo L, Nussdorfer GG (2002) Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypep-tide, and their receptors in the human adrenal gland. J Clin Endocrinol Metab 87:2575-2580
27. Kontogeorgos G, Scheithauer BW, Kovacs K, Horvath E, Melmed S (2002) Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells. Endocr Pathol 13:197-206
28. Grothe C, Meisinger C (1997) The multifunctionality of FGF-2 in the adrenal medulla. Anat Embryol (Berl) 195:103-111
29. Paciga M, Nurse CA (2001) Basic FGF localization in rat carotid body: paracrine role in O2-chemoreceptor survival. Neuroreport 12:3287-3291
30. Verna A (1979) Ulstrastructure of the carotid body in the mammals. Int Rev Cytol 60:271-330
31. Lloyd RV, Blaivas M, Wilson BS (1985) Distribution of chromogr-anin and S-100 protein in normal and abnormal adrenal medullary tissues. Arch Pathol Lab Med 109:633-635
32. Achilles EA, Padberg GC, Holl K, Klöppel G, Schröder S (1991) Immunocytochemistry of paragangliomas-value of staining for S-100 protein and glial fbrillary acidic protein in diagnosis and prognosis. Histopathology 18:453-458
33. Parker TL, Kesse WK, Mohamed AA, Afework M (1993) The innervation of the mammalian adrenal gland. J Anat 183:265-276
34. Portela-Gomes GM, Stridsberg M, Grimelius L, Falkmer UG, Falkmer S (2004) Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specifc antibodies. APMIS 112:663-673
35. Lloyd RV, Sisson JC, Shapiro B, Verhofstad AAJ (1986) Immunohistochemical localization of epinephrine, norepineph-rine, catecholamine-synthesizing enzymes and chromogranin in neuroendocrine cells and tumours. Am J Pathol 125:45-54
36. Portela-Gomes GM, Lukinius A, Grimelius L (2000) Synaptic vesicle protein 2, A new neuroendocrine cell marker. Am J Pathol 157:1299-1309
37. Roth D, Burgoyne RD (1994) SNAP-25 is present in a SNARE complex in adrenal chromaffn cells. FEBS Lett 351:207-210
38. Scopsi L, Gullo M, Rilke F, Martin S, Steiner DF (1995) Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation. J Clin Endocrinol Metab 80:294-301
39. Braas KM, Harakall SA, Ouafk L, Eipper BA, May V (1992) Expression of peptidylglycine alpha-amidating monooxygenase: an in situ hybridization and immunocytochemical study. Endocrinology 130:2778-2788
40. Colombo-Benkmann M, Klimaschewski L, Heym C (1996) Immunohistochemical heterogeneity of nerve cells in the human adrenal gland with special reference to substance P. J Histochem Cytochem 44:369-375
41. Holgert H, Holmberg K, Hannibal J et al (1996) PACAP in the adrenal gland-relationship with choline acetyltransferase, enkephalin and chromaffn cells and effects of immunological sympathectomy. Neuroreport 8:297-301
42. Ichikawa H (2002) Innervation of the carotid body: immunohis-tochemical, denervation, and retrograde tracing studies. Microsc Res Tech 59:188-195
43. Barnes RD, Ward LE, Frank KP et al (2001) Nitric oxide modulates evoked catecholamine release from canine adrenal medulla. Neuroscience 104:1165-1173
44. Baysal BE (2002) Hereditary paraganglioma targets diverse para-ganglia. J Med Genet 39:617-622
45. De Graeff J, Horak BJV (1964) The incidence of pheochromocy-toma in The Netherlands. Acta Med Scand 176:583-593
46. Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT (1983) Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 58:802-804
47. Oosterwijk JC, Jansen JC, van Schothorst EM et al (1996) First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas). J Med Genet 33:379-383
48. Erickson D, Kudva YC, Ebersold MJ et al (2001) Benign paragan-gliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 86:5210-5216
49. Young WF Jr (2006) Paragangliomas: clinical overview. Ann N Y Acad Sci 1073:21-29
50. Tischler AS (2008) Pheochromocytoma and extra-adrenal para-ganglioma: updates. Arch Pathol Lab Med 132:1272-1284
51. Tischler AS (1998) The adrenal medulla and extra-adrenal para-ganglia. In: Kovacs K, Asa SL (eds)) Functional endocrine pathology. Blackwell, Malden
52. Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM (1999) von Recklinghausen's disease and pheochromocytomas. J Urol 162:1582-1586
53. Neumann HP, Bausch B, McWhinney SR et al (2002) Germ-line mutations in nonsyndromic pheochromocytoma. New Engl J Med 346:1459-1466
54. Dahia PL, Hao K, Rogus J et al (2005) Novel pheochromocytoma susceptibility loci identifed by integrative genomics. Cancer res 65:9651-9658
55. Dahia PL, Ross KN, Wright ME et al (2005) A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromo-cytomas. PLoS Genet 1:72-80
56. Tischler AS (2006) Molecular and cellular biology of pheochro-mocytomas and extra-adrenal paragangliomas. Endocr Pathol 17:321-328
57. Dannenberg H, Komminoth P, Dinjens WN, Speel EJ, de Krijger RR (2003) Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas. Endocr Pathol 14:329-350
58. Petri BJ, Speel EJ, Korpershoek E et al (2008) Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas. Mod Pathol 21:407-413
59. Bender BU, Gutsche M, Glasker S et al (2000) Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas. J Clin Endocrinol Metab 85: 4568-4574
60. Jarbo C, Buckley PG, Piotrowski A et al (2006) Detailed assessment of chromosome 22 aberrations in sporadic pheochromocy-toma using array-CGH. Int J Cancer 118:1159-1164
61. Edstrom E, Mahlamaki E, Nord B et al (2000) Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. Am J Pathol 156:651-659
62. Carney A (1983) The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paragan-glioma. Medicine 62:159-169
63. Carney JA, Stratakis CA (2002) Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 108:132-139
64. Kaufman BH, Telander RL, Van Heerden JA et al (1983) Pheochromocytoma in the pediatric age group. J Pediatr Surg 18:879-884
65. Mehra S, Chung-Park M (2005) Gallbladder paraganglioma: a case report with review of the literature. Arch Pathol Lab Med 129:523-526
66. Melicow MM (1977) One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976: a clinicopathological analysis. Cancer 40:1987-2004
67. Gallivan MVE, Chun B, Rowden G, Lack EE (1980) Intrathoracic paravertebral malignant paraganglioma. Arch Pathol Lab Med 104:46-51
68. Quinan C, Berger AA (1933) Observations on human adrenals with especial reference to the relative weight of the normal medulla. Ann Int Med 6:1180-1192
69. Studzinski GP, Hay DCF, Symington T (1963) Observations on the weight of the human adrenal gland and the effect of preparations of corticotropin of different purity on the weight and morphology of the human adrenal gland. J Clin Endocrinol Metab 23:248-254
70. Kreiner E (1982) Weight and shape of the human adrenal medulla in various age groups. Virchows Arch A Pathol Anat Histol 397:7-15
71. DeLellis RA, Wolfe HJ, Gagel RF et al (1976) Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinoma. Am J Pathol 83:177-196
72. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA (1994) Intimate contact of chromaffn and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 78:225-232
73. Schinner S, Bornstein SR (2005) Cortical-chromaffn cell interactions in the adrenal gland. Endocr Pathol 16:91-98
74. Khafagi FA, Shapiro B, Fischer M et al (1991) Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med 18:191-198
75. Stenstrom G, Svardsudd K (1986) Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. Acta Med Scand 220:225-232
76. Hartley L, Perry-Keene D (1985) Phaeochromocytoma in Queensland-1970-83. Aust N Z J Surg 55:471-475
77. McNeil AR, Blok BH, Koelmeyer TD, Burke MP, Hilton JM (2000) Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med 30:648-652
78. Karagiannis A, Mikhailidis DP, Athyros VG, Harsoulis F (2007) Pheochromocytoma: an update on genetics and management. Endocr Relat cancer 14:935-956
79. Vilar L, Freitas Mda C, Canadas V et al (2008) Adrenal incidenta-lomas: diagnostic evaluation and long-term follow-up. Endocr Pract 14:269-278
80. Young WF Jr (2007) Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356:601-610
81. Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J et al (2006) 1, 111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffn tumors. Ann N Y Acad Sci 1073:38-46
82. Bulow B, Ahren B (2002) Adrenal incidentaloma-experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252:239-246
83. Page DL, DeLellis RA, Hough AJ (1985) Tumors of the adrenal. Fascicle 23: atlas of tumor pathology. Armed Forces Institute of Pathology, Washington, DC
84. Remine WH, Chong GC, Van Heerden JA, Sheps SG, Harrison E (1974) Current management of pheochromocytoma. Ann Surg 179:740-748
85. Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y (2005) Histological grading of adrenal and extra-adrenal pheochromocy-tomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 16:23-32
86. Thompson LD (2002) Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26:551-566
87. DeLellis RA, Suchow E, Wolfe HJ (1980) Ultrastructure of nuclear 'inclusions' in pheochromocytoma and paraganglioma. Hum Pathol 11:205-207
88. Medeiros LJ, Wolf BC, Balogh K, Federman M (1985) Adrenal pheochromocytoma: a clinicopathologic review of 60 cases. Hum Pathol 16:580-589
89. Landas SK, Leigh C, Bonsib SM, Layne K (1993) Occurrence of melanin in pheochromocytoma. Mod Pathol 6:175-178
90. Chetty R, Clark SP, Taylor DA (1993) Pigmented pheochromocy-tomas of the adrenal medulla. Hum Pathol 24:420-423
91. Linnoila RI, Keiser HR, Steinberg SM, Lack EE (1990) Histopathology of benign versus malignant sympathoadrenal para-gangliomas: clinicopathologic study of 120 cases, including unusual histologic features. Hum Pathol 21:1168-1180
92. Unger PD, Cohen JM, Thung SN et al (1990) Lipid degeneration in a pheochromocytoma histologically mimicking an adrenal cortical tumor. Arch Pathol Lab Med 114:892-894
93. Ramsay JA, Asa SL, van Nostrand AW, Hassaram ST, de Harven EP (1987) Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors. Am J Surg Pathol 11:480-486
94. Li M, Wenig BM (2000) Adrenal oncocytic pheochromocytoma. Am J Surg Pathol 24:1552-1557
95. Miranda RN, Wu CD, Nayak RN, Kragel PJ, Medeiros LJ (1995) Amyloid in adrenal gland pheochromocytomas. Arch Pathol Lab Med 119:827-830
96. Steinhoff MM, Wells SA Jr, DeSchryver-Kecskemeti K (1992) Stromal amyloid in pheochromocytomas. Hum Pathol 23:33-36
97. Koch CA, Mauro D, Walther MM et al (2002) Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2. Endocr Pathol 13:17-27
98. Kimura N, Nakazato Y, Nagura H, Sasano N (1990) Expression of intermediate flaments in neuroendocrine tumors. Arch Pathol Lab Med 114:506-510
99. Fraga M, Garcia-Caballero T, Antunez J et al (1993) A comparative immunohistochemical study of phaeochromocytomas and paragangliomas. Histol Histopathol 8:429-436
100. Schroder HD, Johannsen L (1986) Demonstration of S-100 protein in sustentacular cells of phaeochromocytomas and paragan-gliomas. Histopathology 10:1023-1033
101. Raghay K, Garcia-Caballero T, Bravo S et al (2008) Ghrelin localization in the medulla of rat and human adrenal gland and in pheo-chromocytomas. Histol Histopathol 23:57-65
102. Morimoto R, Satoh F, Murakami O et al (2008) Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues. Peptides 29:873-880
103. Mazzocchi G, Malendowicz LK, Aragona F et al (2001) Human pheochromocytomas express orexin receptor type 2 gene and display an in vitro secretory response to orexins A and B. J Clin Endocrinol Metab 86:4818-4821
104. Ilias I, Torpy DJ, Pacak K et al (2005) Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 90:4955-4962
105. Aniszewski JP, Young WF Jr, Thompson GB, Grant CS, van Heerden JA (2001) Cushing syndrome due to ectopic adrenocorti-cotropic hormone secretion. World J Surg 25:934-940
106. Meijer WG, Copray SC, Hollema H et al (2003) Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocy-tomas. Clin Chem 49:586-593
107. Kimura N, Miura Y, Nagatsu I, Nagura H (1992) Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol 421:25-32
108. Hayes WS, Davidson AJ, Grimley PM, Hartman DS (1990) Extraadrenal retroperitoneal paraganglioma: clinical, pathologic, and CT fndings. AJR Am J Roentgenol 155:1247-1250
109. Sclafani LM, Woodruff JM, Brennan MF (1990) Extraadrenal ret-roperitoneal paragangliomas: natural history and response to treatment. Surgery 108:1124-1129 discussion 9-30
110. Shono T, Sakai H, Minami Y et al (1999) Paraganglioma of the urinary bladder: a case report and review of the Japanese literature. Urol Int 62:102-105
111. Hirose T, Sano T, Mori K et al (1988) Paraganglioma of the cauda equina: an ultrastructural and immunohistochemical study of two cases. Ultrastruct Pathol 12:235-243
112. Chetty R (1999) Cytokeratin expression in cauda equina paragan-gliomas. Am J Surg Pathol 23:491
113. Cheng L, Leibovich BC, Cheville JC et al (2000) Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer 88:844-852
114. Orrell JM, Hales SA (1992) Paragangliomas of the cauda equina have a distinctive cytokeratin immunophenotype. Histopathology 21:479-481
115. Johnson TL, Zarbo RJ, Lloyd RV, Crissman JD (1988) Paragangliomas of the head and neck: immunohistochemical neu-roendocrine and intermediate flament typing. Mod Pathol 1:216-223
116. Tatekawa Y, Muraji T, Nishijima E, Yoshida M, Tsugawa C (2006) Composite pheochromocytoma associated with adrenal neuroblas-toma in an infant: a case report. J Pediatr Surg 41:443-445
117. Lam KY, Lo CY (1999) Composite pheochromocytoma-ganglion-euroma of the adrenal gland: an uncommon entity with distinctive clinicopathologic features. Endocr Pathol 10:343-352
118. Sakaguchi N, Sano K, Ito M et al (1996) A case of von Recklinghausen's disease with bilateral pheochromocytoma-malig-nant peripheral nerve sheath tumors of the adrenal and gastrointestinal autonomic nerve tumors. Am J Surg Pathol 20:889-897
119. Min KW, Clemens A, Bell J, Dick H (1988) Malignant peripheral nerve sheath tumor and pheochromocytoma. A composite tumor of the adrenal. Arch Pathol Lab Med 112:266-270
120. Miettinen M, Saari A (1988) Pheochromocytoma combined with malignant schwannoma: unusual neoplasm of the adrenal medulla. Ultrastruct Pathol 12:513-527
121. Candanedo-Gonzalez FA, Alvarado-Cabrero I, Gamboa-Dominguez A et al (2001) Sporadic type composite pheochromo-cytoma with neuroblastoma: clinicomorphologic, DNA content and ret gene analysis. Endocr Pathol 12:343-350
122. Lee JH, Barich F, Karnell LH et al (2002) National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 94:730-737
123. Zak FG, Lawson W (1983) The paraganglionic chemoreceptor system. Physiology, pathology and clinical medicine. Springer, New York
124. Parry DM, Li FP, Strong LC et al (1982) Carotid body tumors in humans: genetics and epidemiology. J Natl Cancer Inst 68:573-578
125. Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr (1971) Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg 122:732-739
126. Rodriguez-Cuevas S, Lopez-Garza J, Labastida-Almendaro S (1998) Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck 20:374-378
127. Saldana MJ, Salem LE, Travezan R (1973) High altitude hypoxia and chemodectomas. Hum Pathol 4:251-263
128. Arias-Stella J, Valcarcel J (1973) The human carotid body at high altitudes. Pathol Microbiol 39:292-297
129. Kay JM, Laidler P (1977) Hypoxia and the carotid body. J Clin Pathol Suppl 11:30-44
130. Lack EE (1978) Hyperplasia of vagal and carotid body paragan-glia in patients with chronic hypoxemia. Am J Pathol 91:497-516
131. Heath D (1991) The carotid bodies in chronic respiratory disease. Histopathology 18:281-283
132. Heath D, Edwards C (1971) The carotid body in cardiopulmonary disease. Geriatrics 26:110-111 passim
133. Lack EE, Perez-Atayde AR, Young JB (1985) Carotid body hyper-plasia in cystic fbrosis and cyanotic heart disease. Am J Pathol 119:301-314
134. Bee D, Pallot DJ (1995) Acute hypoxic ventilation, carotid body cell division, and dopamine content during early hypoxia in rats. J Appl Physiol 79:1504-1511
135. Brown JS (1985) Glomus jugulare tumors revisited: a ten-year statistical follow-up of 231 cases. Laryngoscope 95:284-288
136. Imren Y, Tasoglu I, Benson AA, Sinci V (2007) A rare intracardiac mass: cardiac paraganglioma. Heart Lung Circ 16:116-117
137. Fitzgerald PJ, Ports TA, Cheitlin MD, Magilligan DJ, Tyrrell JB (1995) Intracardiac pheochromocytoma with dual coronary blood supply: case report and literature review. Cardiovasc Surg 3:557-561
138. Dresler C, Cremer J, Logemann F, Haverich A (1998) Intrapericardial pheochromocytoma. Thorac Cardiovasc Surg 46:100-102
139. Lack EE (1997) Tumors of the adrenal gland and extra-adrenal paraganglia. Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington DC
140. Leestma JE, Price EB (1971) Paraganglioma of the urinary bladder. Cancer 18:1063-1073
141. Davaris P, Petraki K, Arvanitis D et al (1986) Urinary bladder paraganglioma (U.B.P.). Pathol Res Pract 181:101-106
142. Timmers HJ, Kozupa A, Eisenhofer G et al (2007) Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 92:779-786
143. Bezuglova TV (2003) Criteria for predicting the outcome of pheo-chromocytoma by the immunohistochemical and electron microscopic fndings. Bull Exp Biol Med 136:408-410
144. Unger P, Hoffman K, Pertsemlidis D et al (1991) S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas. Arch Pathol Lab Med 115:484-487
145. Strong VE, Kennedy T, Al-Ahmadie H et al (2008) Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery 143:759-768
146. van der Harst E, Bruining HA, Jaap Bonjer H et al (2000) Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases? J Pathol 191:175-180
147. Clarke MR, Weyant RJ, Watson CG, Carty SE (1998) Prognostic markers in pheochromocytoma. Hum Pathol 29:522-526
148. Garcia-Escudero A, de Miguel-Rodriguez M, Moreno-Fernandez A et al (2001) Prognostic value of DNA fow cytometry in sym-pathoadrenal paragangliomas. Anal Quant Cytol Histol 23:238-244
149. Zhang XH, Wei SL, Wang FR et al (1992) Studies on pathological morphology, clinical features and nuclear DNA contents by fow cytometry in adrenal neoplasms. Chin Med J (Engl) 105:139-143
150. August C, August K, Schroeder S et al (2004) CGH and CD 44/MIB-1 immunohistochemistry are helpful to distinguish metasta-sized from nonmetastasized sporadic pheochromocytomas. Mod Pathol 17:1119-1128
151. Eisenhofer G, Bornstein SR, Brouwers FM et al (2004) Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11:423-436
152. Isobe K, Yashiro T, Omura S et al (2004) Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuro-blastoma tissues. Endocr J 51:47-52
153. Elder EE, Xu D, Hoog A et al (2003) KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheo-chromocytoma and paraganglioma. Mod Pathol 16:246-255
154. Boltze C, Mundschenk J, Unger N et al (2003) Expression profle of the telomeric complex discriminates between benign and malignant pheochromocytoma. J Clin Endocrinol Metab 88:4280-4286
155. Thouennon E, Elkahloun AG, Guillemot J et al (2007) Identifcation of potential gene markers and insights into the pathophysiology of pheo-chromocytoma malignancy. J Clin Endocrinol Metab 92:4865-4872
156. Brouwers FM, Elkahloun AG, Munson PJ et al (2006) Gene expression profling of benign and malignant pheochromocytoma. Ann N Y Acad Sci 1073:541-556
157. Linnoila RI, Lack EE, Steinberg SM, Keiser HR (1988) Decreased expression of neuropeptides in malignant paragangliomas: an immunohistochemical study. Hum Pathol 19:41-50
158. Chetty R, Pillay P, Jaichand V (1998) Cytokeratin expression in adrenal phaeochromocytomas and extra-adrenal paragangliomas. J Clin Pathol 51:477-478
159. Beltrami CA, Barbatelli G, Criante P, Paliaga A, Amadi CE (1987) An immunohistochemical study in thyroid cancer. Appl Pathol 5:229-245
160. Rosai J (2003) Immunohistochemical markers of thyroid tumors: signifcance and diagnostic applications. Tumori 89:517-519
161. Batistatou A, Zolota V, Scopa CD (2002) S-100 protein+ dendritic cells and CD34+ dendritic interstitial cells in thyroid lesions. Endocr Pathol 13:111-115
162. Collina G, Maiorana A, Fano RA, Cesinaro AM, Trentini GP (1994) Medullary carcinoma of the thyroid gland with sustentacu-lar cell-like cells in a patient with multiple endocrine neoplasia, type IIA. Report of a case with ultrastructural and immunohis-tochemical studies. Arch Pathol Lab Med 118:1041-1044
163. Hirokawa M, Carney JA, Ohtsuki Y (2000) Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns. Am J Surg Pathol 24:877-881
164. Fornes P, Lesourd A, Dupuis G et al (1990) Hyalinizing trabecular adenoma of the thyroid gland. Histologic and immunohistochemi-cal study. Report of 2 cases. Arch Anat Cytol Pathol 38:203-207
165. Ferlito A, Friedmann I (1991) Contribution of immunohistochem-istry in the diagnosis of neuroendocrine neoplasms of the larynx. ORL J Otorhinolaryngol Relat Spec 53:235-244
166. Komminoth P, Roth J, Schroder S, Saremaslani P, Heitz PU (1995) Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Lab Invest 72:424-431
167. Haak HR, Fleuren GJ (1995) Neuroendocrine differentiation of adrenocortical tumors. Cancer 75:860-864
168. Zhang H, Bu H, Chen H et al (2008) Comparison of immunohis-tochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors. Appl Immunohistochem Mol Morphol 16:32-39
169. Zhang PJ, Genega EM, Tomaszewski JE, Pasha TL, LiVolsi VA (2003) The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immu-nohistochemical study. Mod Pathol 16:591-597
170. Munro LM, Kennedy A, McNicol AM (1999) The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. J Endocrinol 161:341-347
171. McCluggage WG, Burton J, Maxwell P, Sloan JM (1998) Immunohistochemical staining of normal, hyperplastic, and neo-plastic adrenal cortex with a monoclonal antibody against alpha inhibin. J Clin Pathol 51:114-116
172. Jungbluth AA, Busam KJ, Gerald WL et al (1998) A103: An anti-melan-A monoclonal antibody for the detection of malignant melanoma in paraffn-embedded tissues. Am J Surg Pathol 22:595-602
173. Laforga JB, Aranda FI (1994) HMB-45 reactivity in sustentacular cells of paragangliomas. Histopathology 24:199
174. Caya JG (1994) HMB-45 reactivity in adrenal pheochromocy-tomas. Arch Pathol Lab Med 118:1169
175. Bastide C, Arroua F, Carcenac A et al (2006) Primary malignant melanoma of the adrenal gland. Int J Urol 13:608-610
176. Amerigo J, Roig J, Pulido F et al (2000) Primary malignant melanoma of the adrenal gland. Surgery 127:107-111
177. Visser JW, Axt R (1975) Bilateral adrenal medullary hyperplasia: a clinicopathological entity. J Clin Pathol 28:298-304
178. Dobbie JW, Symington T (1966) The human adrenal gland with special reference to the vasculature. J Endocrinol 34:479-489
179. Carney JA, Sizemore GW, Sheps SG (1976) Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocy-toma and its precursors. Am J Clin Pathol 66:279-290
180. Diaz-Cano SJ, de Miguel M, Blanes A et al (2000) Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyper-plasias: histological and kinetic correlates. J Pathol 192:221-228
181. Montalbano FP, Baronofsky ID, Ball H (1962) Hyperplasia of the adrenal medulla. JAMA 182:264-267
182. Bisceglia M, Nirchio V, Attino V et al (1998) 'Black adenoma'; associated with medullary nodular hyperplasia in the ipsilateral adrenal gland. Case report and review of the literature regarding 'mixed' cortico-medullary pathology. Pathologica 90:306-312
183. Borrero E, Katz P, Lipper S, Chang JB (1987) Adrenal cortical adenoma and adrenal medullary hyperplasia of the right adrenal gland-A case report. Angiology 38:271-274